346 related articles for article (PubMed ID: 11213831)
1. The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.
Mentzel T; Brown LF; Dvorak HF; Kuhnen C; Stiller KJ; Katenkamp D; Fletcher CD
Virchows Arch; 2001 Jan; 438(1):13-22. PubMed ID: 11213831
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
4. VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary.
Orre M; Rogers PA
Int J Cancer; 1999 Apr; 84(2):101-8. PubMed ID: 10096239
[TBL] [Abstract][Full Text] [Related]
5. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
6. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
[TBL] [Abstract][Full Text] [Related]
8. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
9. Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation.
Jacobs TW; Schnitt SJ; Tan X; Brown LF
Hum Pathol; 2002 Jan; 33(1):29-38. PubMed ID: 11823971
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.
Hoshino M; Nakamura Y; Hamid QA
J Allergy Clin Immunol; 2001 Jun; 107(6):1034-8. PubMed ID: 11398081
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.
Plate KH; Breier G; Weich HA; Mennel HD; Risau W
Int J Cancer; 1994 Nov; 59(4):520-9. PubMed ID: 7525492
[TBL] [Abstract][Full Text] [Related]
12. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
[TBL] [Abstract][Full Text] [Related]
13. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression.
Kanellis J; Paizis K; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
Kidney Int; 2002 May; 61(5):1696-706. PubMed ID: 11967019
[TBL] [Abstract][Full Text] [Related]
14. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.
Endo T; Kitajima Y; Nishikawa A; Manase K; Shibuya M; Kudo R
Fertil Steril; 2001 Oct; 76(4):762-8. PubMed ID: 11591411
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
[TBL] [Abstract][Full Text] [Related]
16. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
[TBL] [Abstract][Full Text] [Related]
17. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
Ohta Y; Shridhar V; Bright RK; Kalemkerian GP; Du W; Carbone M; Watanabe Y; Pass HI
Br J Cancer; 1999 Sep; 81(1):54-61. PubMed ID: 10487612
[TBL] [Abstract][Full Text] [Related]
18. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
19. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma.
Hashimoto M; Ohsawa M; Ohnishi A; Naka N; Hirota S; Kitamura Y; Aozasa K
Lab Invest; 1995 Dec; 73(6):859-63. PubMed ID: 8558848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
